Ferozsons teams up with Gilead to manufacture HIV drug in Pakistan
Ferozsons Laboratories Limited (PSX: FEROZ) has secured a non-exclusive voluntary license agreement with Gilead Sciences Ireland UC, allowing it to manufacture and sell generic versions of the HIV drug lenacapavir. The partnership aims to provide high-quality, affordable HIV treatment in resource-constrained, high-burden countries across the developing world. Ferozsons is one
